The MyoVista® Wavelet ECG (wavECG™) Device introduces breakthrough technology that is designed to assist in the early detection of heart disease*. The MyoVista wavECG Device is an innovative advancement for low-cost electrocardiographic testing. It uses advanced signal processing that features the use of wavelet mathematics. Wavelet mathematics are used in many different industries today since new potentially valuable information is provided from spectral analysis of a signal. MyoVista wavECG Technology benefits from more than 10 years of progressive research and development.

*MyoVista® Wavelet ECG provides clinically-relevant reproducible and quantitative data intended to be used to support qualified cardiologist and other licensed healthcare professionals for clinical decision-making. It is a support tool that provides relevant clinical data as a resource to the clinician and is not intended to be a source of medical advice or to determine or recommend a course of action or treatment for a patient.